Earnings

aTyr Pharma Q3 EPS $(7.43) Misses $(4.00) Estimate

Nov 5, 2026 · 04:25 PM ET· updated 1h ago

aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(4.00) by 85.75 percent. This is a 2757.69 percent decrease over losses of $(0.26) per share from

Why It Matters

aTyr Pharma lost much more money per share than experts predicted this quarter. When a company's losses grow that fast, watch to see if they can control spending or find new revenue.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ATYR5.88

-0.30 (-4.85%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.